509 results on '"Shen, Liangfang"'
Search Results
2. Nivolumab combined with chemoradiotherapy sparing concurrent cisplatin in high-risk locoregionally advanced nasopharyngeal carcinoma (PLATINUM): A multicenter, single-arm, phase II clinical trial.
3. PD-1 blockade with camrelizumab after chemoradiotherapy in nasopharyngeal carcinoma.
4. Lactobacillus rhamnosus GG ameliorates radiation-induced lung fibrosis via lncRNASNHG17/PTBP1/NICD axis modulation
5. Tumor volume reduction after induction chemotherapy with gemcitabine plus cisplatin in nasopharyngeal carcinoma
6. E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression
7. Prognostic analysis and nomogram construction for older patients with IDH-wild-type glioblastoma
8. HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma
9. Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study
10. Retraction Note: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
11. Adjuvant PD-1 blockade with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma (DIPPER): A multicenter, open-label, phase 3, randomized controlled trial.
12. Nivolumab combined with radical chemoradiotherapy sparing concurrent cisplatin in high-risk locoregionally advanced nasopharyngeal carcinoma (PLATINUM): An investigator-initiated, open-label, multicenter, single-arm, phase II clinical trial.
13. Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencing
14. SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
15. Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
16. Integrative analysis reveals the functional implications and clinical relevance of pyroptosis in low-grade glioma
17. Potential role of gut microbiota-LCA-INSR axis in high fat-diet-induced non-alcoholic fatty liver dysfunction: From perspective of radiation variation
18. BET protein degradation triggers DR5-mediated immunogenic cell death to suppress colorectal cancer and potentiate immune checkpoint blockade
19. Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
20. Prognostic factors in surgically treated tongue squamous cell carcinoma in stage T1‐2N0‐1M0: A retrospective analysis
21. Prognosis Forecast of Re-Irradiation for Recurrent Nasopharyngeal Carcinoma Based on Deep Learning Multi-Modal Information Fusion
22. CRISPR/Cas9 genome-wide screening identifies LUC7L2 that promotes radioresistance via autophagy in nasopharyngeal carcinoma cells
23. Preoperative Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Biomarker in Patients with Low-Grade Gliomas
24. Efficacy and safety of Genolimzumab in previously treated PD-L1-Positive recurrent or metastatic cervical cancer: a multicenter open-label, single-arm, phase Ⅱ study
25. CTNI-20. NIMOTUZUMAB COMBINED WITH CONCURRENT CHEMORADIOTHERAPY IN THE TREATMENT OF NEWLY DIAGNOSED PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
26. Integrative analyses reveal biological function and prognostic role of m7G methylation regulators in high-grade glioma
27. EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma
28. Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
29. CT-based radiomics for predicting radio-chemotherapy response and overall survival in nonsurgical esophageal carcinoma
30. WITHDRAWN: P53-response circRNA_0006420 aggravates lung cancer radiotherapy resistance by promoting formation of HUR/PTBP1 complex
31. Cascaded Nanozyme with In‐Situ Enhanced Photothermal Capacity for Tumor‐Specific and Self‐Replenishing Cancer Therapy
32. Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response
33. Emerging role of inositol monophosphatase in cancer
34. Contribution of whole slide imaging‐based deep learning in the assessment of intraoperative and postoperative sections in neuropathology
35. Retraction notice to “Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway” [Canc. Lett. 436 (2018) 119–128]
36. Data from BET Inhibitors Potentiate Chemotherapy and Killing of SPOP-Mutant Colon Cancer Cells via Induction of DR5
37. Supplementary Data from BET Inhibitors Potentiate Chemotherapy and Killing of SPOP-Mutant Colon Cancer Cells via Induction of DR5
38. Integrative Analysis of the Predictive Value of Perilipin Family on Clinical Significance, Prognosis and Immunotherapy of Glioma
39. Effect of radiochemotherapy on the cognitive function and diffusion tensor and perfusion weighted imaging for high-grade gliomas: A prospective study
40. The regulation of radiosensitivity by p53 and its acetylation
41. Tumor volume reduction after induction chemotherapy with gemcitabine plus cisplatin in nasopharyngeal carcinoma
42. CT-based radiomics for predicting radio-chemotherapy response and overall survival in nonsurgical esophageal carcinoma
43. Integrative analyses reveal prognostic and immunogenic characteristics of m7G methylation regulators in patients with glioma
44. MDK induces temozolomide resistance in glioblastoma by promoting cancer stem-like properties
45. Comprehensive analysis of the expression profile and clinical implications of regulator of chromosome condensation 2 in pan-cancers
46. Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma
47. UBE2T promotes glioblastoma malignancy through ubiquitination‐mediated degradation of RPL6
48. Comprehensive analyses reveal the role of histone deacetylase genes in prognosis and immune response in low-grade glioma
49. E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression
50. Pan-cancer analysis of a novel indicator of necroptosis with its application in human cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.